학술논문
Trastuzumab deruxtecan vs physician's choice in patients with HER2+unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine: primary results of the randomized, phase 3 study DESTINY-Breast02
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445